Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 2;12(9):2490.
doi: 10.3390/cancers12092490.

Single-Cell NGS-Based Analysis of Copy Number Alterations Reveals New Insights in Circulating Tumor Cells Persistence in Early-Stage Breast Cancer

Affiliations

Single-Cell NGS-Based Analysis of Copy Number Alterations Reveals New Insights in Circulating Tumor Cells Persistence in Early-Stage Breast Cancer

Tania Rossi et al. Cancers (Basel). .

Abstract

Circulating tumor cells (CTCs) are a rare population of cells representing a key player in the metastatic cascade. They are recognized as a validated tool for the identification of patients with a higher risk of relapse, including those diagnosed with breast cancer (BC). However, CTCs are characterized by high levels of heterogeneity that also involve copy number alterations (CNAs), structural variations associated with gene dosage changes. In this study, single CTCs were isolated from the peripheral blood of 11 early-stage BC patients at different time points. A label-free enrichment of CTCs was performed using OncoQuick, and single CTCs were isolated using DEPArray. Libraries were prepared from single CTCs and DNA extracted from matched tumor tissues for a whole-genome low-coverage next-generation sequencing (NGS) analysis using the Ion Torrent S5 System. The analysis of the CNA burden highlighted that CTCs had different degrees of aberration based on the time point and subtype. CTCs were found even six months after surgery and shared CNAs with matched tumor tissue. Tumor-associated CNAs that were recurrent in CTCs were patient-specific, and some alterations involved regions associated with BC and survival (i.e., gains at 1q21-23 and 5p15.33). The enrichment analysis emphasized the involvement of aberrations of terms, associated in particular with interferon (IFN) signaling. Collectively, our findings reveal that these aberrations may contribute to understanding the molecular mechanisms involving CTC-related processes and their survival ability in occult niches, supporting the goal of exploiting their application in patients' surveillance and follow-up.

Keywords: CNA; CTCs; NGS; breast cancer; liquid biopsy; single-cell analysis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Violin plots showing the distribution of the Jaccard Indexes (JIs) computed by comparing the copy number alteration (CNA) profile of single circulating tumor cells (CTCs) and controls in non-triple negative breast cancer (TNBC) against TNBC.
Figure 2
Figure 2
Violin plots showing the distribution of the Jaccard Indexes (JIs) computed by comparing the copy number alteration (can) profile of single circulating tumor cells (CTCs) and matched tumor tissue in non-triple negative breast cancer (TNBC) against TNBC.
Figure 3
Figure 3
Violin plots showing the distribution of the Jaccard Indexes (JIs) computed by comparing the copy number alteration (can) profile of single circulating tumor cells (CTCs) and control at the access times (A) (n = 24), (B) (n = 13) and (C) (n = 12).
Figure 4
Figure 4
Violin plots showing the distribution of the Jaccard Indexes (JIs) computed by comparing the copy number alteration (CNA) profile of single circulating tumor cells (CTCs) and matched tumor tissue at the access times (A) (n = 24), (B) (n = 13) and (C) (n = 12).

References

    1. Pantel K., Speicher M.R. The biology of circulating tumor cells. Oncogene. 2016;35:1216–1224. doi: 10.1038/onc.2015.192. - DOI - PubMed
    1. Fares J., Fares M.Y., Khachfe H.H., Salhab H.A., Fares Y. Molecular principles of metastasis: A hallmark of cancer revisited. Signal Transduct. Target. Ther. 2020;5:28. doi: 10.1038/s41392-020-0134-x. - DOI - PMC - PubMed
    1. Sarangi S., Mosalpuria K., Higgins M.J., Bardia A. The Evolving Role of Circulating Tumor Cells in the Personalized Management of Breast Cancer: From Enumeration to Molecular Characterization. Curr. Breast Cancer Rep. 2014;6:146–153. doi: 10.1007/s12609-014-0149-9. - DOI - PMC - PubMed
    1. Mocellin S., Keilholz U., Rossi C.R., Nitti D. Circulating tumor cells: The ‘leukemic phase’ of solid cancers. Trends Mol. Med. 2006;12:130–139. doi: 10.1016/j.molmed.2006.01.006. - DOI - PubMed
    1. Rossi E., Zamarchi R. Single-Cell Analysis of Circulating Tumor Cells: How Far Have We Come in the -Omics Era? Front. Genet. 2019;10 doi: 10.3389/fgene.2019.00958. - DOI - PMC - PubMed

LinkOut - more resources